Recombinant Human Fibronectin ,rFN is a recombinant human fibronectin extracted from rice endosperm cells and exists in monomeric form [1]. Recombinant Human Fibronectin ,rFN can be used as a cell culture matrix to replace Matrigel, rat tail collagen, blood-derived fibronectin, etc., to increase cell adhesion rate, enhance cell metabolism level and shorten cell growth cycle. Recombinant Human Fibronectin ,rFN can also be directly added to the culture medium to replace or reduce the amount of serum, promote cell adhesion, migration, suspension growth and maintain a good cell state [2].
Fibronectin (FN) is a soluble glycoprotein that exists in body fluids and can also be one of the insoluble components of the extracellular matrix. FN as one of the main cell adhesion molecules, FN plays a key role in important physiological processes such as embryonic development, wound healing, hemostasis and thrombosis [3]. FN can also bind to a variety of extracellular matrix proteins (such as collagen, fibrin and heparin sulfate proteoglycans), thereby participating in the construction and regulation of the extracellular environment [4].
References:
[1]. Dong Y, Zhu W, Lei X, et al. Treatment of acute wounds with recombinant human-like collagen and recombinant human-like fibronectin in C57BL/6 mice individually or in combination[J]. Frontiers in Bioengineering and Biotechnology, 2022, 10: 908585.
[2]. Patten, Jennifer, Karin Wang. "Fibronectin in development and wound healing." Advanced drug delivery reviews 170 (2021): 353-368.
[3]. Mathew-Steiner SS, Roy S, Sen CK. Collagen in wound healing. Bioengineering. 2021 May 11; 8(5): 63.
[4]. Pankov R, Yamada KM. Fibronectin at a glance. Journal of cell science. 2002 Oct 15; 115(20): 3861-3863.
















